Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

The Second Affiliated Hospital Of Fujian Medical University

Clinical trials sponsored by The Second Affiliated Hospital Of Fujian Medical University, explained in plain language.

Not yet recruiting 1

Experimental cell therapy takes aim at tough lymphoma

Disease control Not yet recruiting

This early-phase study tests an experimental therapy called QH103, made from special immune cells (γδT cells) engineered to find and attack cancer cells that carry a protein called CD19. The study will enroll 6 adults whose B-cell lymphoma has returned or not responded to standar…

Phase: PHASE1 • Sponsor: The Second Affiliated Hospital of Fujian Medical University • Aim: Disease control

Last updated May 18, 2026 12:10 UTC